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Among all of the many examples of mobile elements or ‘‘parasitic
sequences’’ that affect the function of the human genome, this
paper describes several examples of functioning genes whose
sequences have been almost completely derived from mobile
elements. There are many examples where the synthetic coding
sequences of observed mRNA sequences are made up of mobile
element sequences, to an extent of 80% or more of the length of
the coding sequences. In the examples described here, the genes
have named functions, and some of these functions have been
studied. It appears that each of the functioning genes was origi-
nally formed from mobile elements and that in some process of
molecular evolution a coding sequence was derived that could be
translated into a protein that is of some importance to human
biology. In one case (AD7C), the coding sequence is 99% made up
of a cluster of Alu sequences. In another example, the gene BNIP3
coding sequence is 97% made up of sequences from an apparent
human endogenous retrovirus. The Syncytin gene coding sequence
appears to be made from an endogenous retrovirus envelope
gene.
Mobile elements form the majority of the human genome,but that is unimportant compared to all of the functional
effects these ‘‘parasites’’ have had on our evolution. Insertions
have influenced the regulation of transcription of some genes
and the termination of transcription. Hundreds of examples have
been recognized where individual exons have sequences that are
similar or identical to fragments of mobile element (ME)
sequences (1, 2). In many of these cases a single exon is involved,
and its transcription yields a variant mRNA (3). The suggestion
is that MEs are a source of variation as a result of the insertion
of fragments of sequence into functioning genes. Here, I am
using MEs (sensu lento) to represent any repeated sequence
present in many copies in the genome. Smit (4) has made a list
of 19 examples of human genes ‘‘probably derived from trans-
posable elements.’’
Reported here are cases where almost the entire coding
sequences (89%) of functioning human genes are apparently
derived fromME sequences. There are several examples of genes
with named functions in which all or nearly all of coding
sequences are quite similar to ME sequences as recognized by
REPEATMASKER (www.repeatmasker.org). There are many other
examples of observed mRNAs for which the coding sequences
are defined by computer programs, and these sequences are
identified by REPEATMASKER as MEs. However, in this subset of
cases it is claimed that a functioning gene was derived entirely
from ME sequences. There may be additional cases among a list
of 49 unstudied examples derived by screening mRNA libraries
to be described below.
These observations contribute an additional bit to the growing
mass of evidence that indicates that mobile elementsrepeats are
not always junk and have made important contributions to the
‘‘host’’ (5–9). The MEs and DNA sequences derived from them
have been a part of the eukaryotic ‘‘genomic environment’’ for
a very long time. Thus, it is expected that they will have had
important effects on gene function because it can be considered
that living systems will sooner or later make use of whatever is
available if it is at all possible, particularly in the genome. There
have been theoretical proposals (10) of the evolutionary role of
variety and change in these relationships, particularly in the
control of gene expression. There is direct evidence for the
evolutionarily significant role of mobile elementsrepeats (11–
13) and evidence for strong associations and functions including
the regulation of transcription. The cases described in this paper
add to this earlier evidence in that, in these cases, nearly the
entire coding sequences of genes have apparently been derived
from ME sequences.
A survey is in process to determine the fraction of the coding
sequences recognized at present in available genomes that are
derived from ME sequences. The early results turned up the
AD7C or neural thread protein gene, which sparked interest
because it is apparently derived entirely from a cluster of Alu
repeated sequences. The investigators pointed out that the
coding sequence contained regions of sequence similarity to four
Alu sequences (14). Table 1 describes this and several other
cases.
Methods
A collection of coding sequences was made from the NCBI file
seqgene.md. These were examined by REPEATMASKER, and
those that were reported to be almost completely similar in
sequence to mobile elements were set aside for further study.
The examples examined in the first part of this paper were
selected from this list on the basis of their known function. Some
of the remainder of them are shown in Table 4.
Results and Discussion
AD7C. AD7C is a neuronal thread protein gene. It encodes a
41-kDa membrane spanning phosphoprotein that is useful in the
diagnosis of early Alzheimer’s disease (14, 15). The coding
sequence is 1,128 nt long and REPEATMASKER shows that it
consists of fragments of five (or four, see below) Alu sequences.
All of the matches are with the reverse complements of the Alu
repeats. The alignment is summarized in Table 2. Listed are the
percent similarity and length of each of the regions from the best
matching Alu sequences, which differ inconsequentially from
those published in ref. 14.
First, an AluSp matches at 92% accuracy the first 281 nt of the
coding sequence. After a gap of 3 nt, 141 nt of AluJo matches at
87% precision. Then, after 2 nt, an additional part of the AluJo
sequence matches to 93% for 167 nt including a sizeable part of
the poly(A) tail, modified by two substitutions that affect the
translation. These two short fragments seem to represent one
Alu sequence homolog in the coding sequence, but rearrange-
ment has apparently occurred because there are overlapping
regions of the AluJo. Next is a 92% match for 302 nt to an AluSc,
including a sizeable part of the poly(A) tail that is modified.
Finally, there is an 88% match for 239 nt to an AluSx, also
including a sizeable region of the poly(A) tail that is modified.
In the genome, this match continues after the end of the coding
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sequence region and there is another match to an Alu sequence
(data not shown).
It appears that the whole gene coding region has been made
from a cluster of Alu sequences. The gaps of a few nucleotides
between the individual Alu sequence matches are probably just
details of the REPEATMASKER alignment process and can be
ignored. A matter of interest is how much change has occurred
in the sequences to form a useful gene from the ME sequences.
The Alu sequences summarized in Table 2 are simply the best
matches from the REPEATMASKER collection and are not nec-
essarily the Alu sequences that were present in the original Alu
cluster, so that it is not possible in general to identify the
sequence changes that have occurred. A sample can be estimated
by examining the three poly(A) chains that are included. They
total to 60 Ts in the complementary Alu sequences. In these
poly(T) regions, eight changes have occurred, all leading to
translatable codons for amino acids other than phenylalanine.
They consist of six A substitutions and two insertions of two As
each. This 17% change in this small sample suggests positive
selection. Of course, there is only one possible silent substitution
in a row of Ts, the transition from T to C in the third base. In
addition, there are four cases of internal T-rich sequences in the
five Alu sequences involved, and in one of those, such a silent
substitution has occurred. In two of these cases, length differ-
ences have occurred resulting from a six-base deletion and a
four-base insertion, leading, of course, to translatable codons.
This is a clear case in which a cluster of Alu repeats has been
converted into an active human gene. We do not yet know how
the 5 control region is organized. With that information we will
someday be able to say more about the evolutionary process that
created the gene. It was pointed out that an identifiable full-
length representation in the human genome (build 34) is only
97% similar to the AD7C mRNA sequence (A. F. Smit, personal
communication) (14). The differences are such that the genomic
sequence is not translatable for a significant length. No better
genomic copy of the mRNA has been found, but the gene could
contain introns and might be hard to identify because of the Alu
sequences.
BNIP3. BNIP3 is the gene for a protein involved in controlling
apoptosis through the interaction with other proteins (16–18).
The heading for the entry in OMIM (Online Mendelian Inher-
itance in Man) is BCL2ADENOVIRUS E1B 19KD PRO-
TEIN-INTERACTING PROTEIN 3: BNIP3. Table 1 shows
that 97% of the coding sequence is related closely to that of
HERV70RM. HERV70RM is the name I am using for the
version of HERV70 that is included in the REPEATMASKER
library and it is named a human endogenous retrovirus, although
it does not contain recognizable retroviral gene residues. It is
more than 7 kb long, and the relationships to the BNIP3 coding
sequence occurs after nucleotide 4641 of HERV70RM. The
coding sequence of the BNIP3 mRNA aligns fully with the
HERV70RM sequence even though the gene consists of 6 exons
spread over almost 15 kb of DNA. To help resolve this relation-
ship, REPEATMASKER was run against the whole gene, and the
results are shown in Table 3. Most of these data are from
REPEATMASKER output, and two columns are added to show the
location of the exons in the gene. In most cases, the identification
of an HERV70RM segment in the gene aligns closely with the
exons. This agreement is so good that the history seems obvious.
Likely, a part of the HERV70RM from about 4–7 kb was
converted to a gene without introns, which must have evolved
and become useful, and later the introns were inserted into it to
lead to the modern BNIP3 gene. In fact, there is a BNIP3P
sequence on chromosome 14 that is identified as a pseudogene
because it lacks introns and gives a very good match in a search
made with the BNIP3mRNAby using BLAST the human genome.
It is possibly a fossil of the early stage in this event or it may be
an actual pseudogene made from the mRNA at a later stage.
To further explore this interpretation, the coding sequence
was aligned with the HERV70RM sequence by using BLAST2
sequences. The result showed two copies of the almost complete
cds region at locations 5507–6073 and 6732–7289 in the
HERV70RM sequence, matching 80%. Thus, the locations
shown in Table 3 in HERV70RM are simply the best fits of
REPEATMASKER and do not necessarily show the actual sequence
origins of the BNIP3 coding sequence. It seems likely that it
originated as a copy of one of the regions in HERV70RM. Table
3 shows one example of a sequence similarity between
HERV70RM and a region of the gene that is not an exon in
BNIP3. The history of this region is unclear. In any case, it is
clear that most of the exons of the BNIP3 gene derived from a
continuous stretch of HERV70RM. This seems to be a good case
of ‘‘introns late’’ because there is no other explanation that
comes to mind for the presence of a series of connected pieces
of HERV70RM spread widely in the BNIP3 gene.
An important issue is the nature of HERV70RM. The copy
used in these studies is listed in the library of human repeated
sequences listed in REPEATMASKER. It is incomplete and not a
classical endogenous retrovirus. The HERVD database (http:
herv.img.cas.cz) lists many regions in the human genome that are
similar in sequence to what I call HERV70RM here, although
none of them match a length of more than 1 kb. In fact, there
Table 1. Selected genes derived from ME sequences
Chr. Name cds, nt % ME % match ME identifier Accession no.
1? AD7c 1,128 99.6 83–92 5 Alu segments NM014486
7 SYNCYTIN 1,615 100 97 HERV-W AF072506
(7 GTF2IRD2* 1,607 97.7 80–88 Charlie8, DNAMER1 NM001003795)
8 HHCM 1,404 89.9 68–71 L1MD2, LINEL1 NM006543
10 BNIP3 585 97.1 84 HERV70, LTRERV1 NM004052
13 LG30 216 100 74–76 MLT1E, MLT1G, LTR AY138548
The first column is the chromosome (Chr.) number, which is not certain for AD7C.
*Exon 16 only, therefore in parentheses.
Table 2. Alignment summary of AD7C
Position in ME§
%* Start End† ME‡ End Start
92 1 281 AluSp#SINEAlu 280 1
87 284 411 AluJo#SINEAlu 143 2
83 413 580 AluJo#SINEAlu 301 134
92 581 884 AluSc#SINEAlu 302 1
88 887 1128 AluSx#SINEAlu 300 61
*Match between ME sequence and region of cds.
†Start and end positions in cds.
‡REPEATMASKER description of ME.
§End and start positions in reverse-oriented ME.
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is a set of 63 sequences in this database that match the BNIP3
cds, although most of them show only a short matching region.
The situation needs clarification because there are many entries
in the HERVD database called HERV70 that show no sequence
similarity to HERV70RM. There is no full-length copy of
HERV70RM in the present version of the human genome, so its
status as a human endogenous retrovirus sequence is doubtful.
BLAST of the human genome (filter off) searching with
HERV70RM finds many hits and graphs some examples as if
they were full-length matches. They do not exist, and the
program has assembled them from groups of nearby fragmen-
tary matches.
When REPEATMASKER is run against HERV70RM, two small
fragments of Alu sequences are found, as well as other MEs
within it. There are regions that REPEATMASKER identifies as
HERV70 (HERV70RM), and these include the region of the
copies of the BNIP3 coding sequences. A warning is required
here because BLAST of the human genome (filter off, default)
finds only 3 matching sequences for the BNIP3 coding sequence
of the 63 that exist in the HERVD database. I confirm the fact that
there aremanymatching fragments to the coding sequence (cds),
finding 120 in the human genome by using BLAST. This is an
important point because these data, regardless of the interpre-
tation of HERV70RM, show that the BNIP3 gene cds sequence
is closely related in toto to sequences of a ME. We may not know
exactly what this ME is, but there are many copies of this region
of it in the human genome ranging from precise to quite
divergent.
The BNIP3 gene occurs in the mouse genome [NM009760],
and the coding sequence matches the human with 89% accu-
racy. The protein sequences match to 90% accuracy except for
a 5-aa gap and a 1-aa gap in the mouse protein. The gene
arrangement is similar, with 6 exons extending over 15 kb.
The exons are identical in length to the human exons except for
the gaps of 15 and 3 nt corresponding to the protein differ-
ences. Because the cds match so closely in sequence, the mouse
BNIP3 exons show the same relationship to the human
HERV70RM as do the human BNIP3 exons. Interestingly,
there is no sequence in the mouse genome, seen by BLAST of
the mouse genome, that matches the human HERV70RM
except for the BNIP3 exons. There is apparently no equivalent
ERV in mouse genome, although, of course, many other
HERVs and MERVs share sequence. REPEATMASKER may be
used with either the human repeats or mouse repeats to
examine the mouse BNIP3 gene region. With the human
repeats, the mouse BNIP3 exons are recognized as
HERV70RM sequences, but with the mouse repeats, no
sequences match. The exons in the two genes are nearly
identical. The nucleotide sequences of the mouse and human
BNIP3 cds match closely (90%). Ks between the coding
sequences of mouse and human are 0.41 and Ka  0.047 (Ks is
the divergence due to synonymous substitutions, and Ka is the
divergence due to changes that cause amino acid replacement)
(19). This similarity suggests that whatever the events were,
they occurred far in the past.
The BNIP3 gene has also been sequenced from rat, and the
cds is 95% similar to that of mouse BNIP3, so the same
arguments apply. The Ks between the coding sequences of the
rat and human is 0.37 and Ka  0.048 (20). BLAST of the rat
genome finds a BNIP3 exon and two other rat sequences
similar to parts of human HERV70RM, whereas BLAST of the
mouse genome finds only a BNIP3 exon with similarity to
human HERV70RM. Based on a BLAST search of GenBank,
chicken (Gallus gallus) has a similar mRNA sequence to the
human BNIP3. There is a match of 367 of 453 nt, or 81%, in
one large region and evidence of other smaller regions of
similarity. It seems that a full examination of the evolution and
relationships of BNIP3 and HERV70RM would be worthwhile
in a number of species.
Table 3. MEs in the BNIP3 gene
Divergence Distance from start of gene
ME identification
Location in ME
% Del Ins Exon Start End Start End
17.6 8.0 3.2 824 869 1 875  HERV70 LTRERV1 4641 5557
26.1 0.0 4.2 1241 1288 C L2 LINEL2 (86) 3227
28.3 16.3 0.0 1648 1739 C MER5A DNA
MER1type
(48) 141
9.0 4.1 0.0 2208 2473  AluSq SINEAlu 1 277
23.7 12.6 2.1 2753 2847  L1ME3A LINEL1 6021 6125
18.0 0.0 0.0 2938 3087 2937 3086  HERV70 LTRERV1 6776 6925
16.2 0.0 3.7 3164 3270 3169 3277  HERV70 LTRERV1 6933 7037
15.8 11.4 0.0 4574 4687  FLAMC SINEAlu 1 127
13.8 0.0 0.0 5334 5418 5335 5421  HERV70 LTRERV1 7032 7118
13.6 1.3 0.0 6093 6243 6094 6247  HERV70 LTRERV1 5901 6056
19.3 2.8 0.0 6691 6980 C AluJo SINEAlu (14) 298
32.0 8.0 0.0 6997 7146 C L1ME LINEL1 (734) 5436
7.0 1.1 1.1 None 7147 7233  HERV70 LTRERV1 7172 7258
27.5 5.6 1.4 7241 7384 C L1ME LINEL1 (873) 5273
23.0 18.6 2.3 8613 8870 C MER21C LTRERV1 (88) 847
17.9 0.0 11.8 8909 8984  (CCCCAA) n Simplerepeat 2 68
16.7 0.0 1.6 9224 9284  MER41B LTRERV1 481 540
8.3 1.4 0.7 9297 9586  AluSq SINEAlu 6 297
24.1 3.7 3.7 9594 9675 C MER21C LTRERV1 (853) 82
23.7 17.2 0.0 9747 10036 C MLT1A0 LTRMaLR (17) 348
34.9 1.8 3.6 11487 11596  MIR3 SINEMIR 101 208
21.7 4.7 3.5 11902 11987  FRAM SINEAlu 75 161
4.7 3.0 3.0 12762 12892  AluJoFLAM SINEAlu 1 131
14061 14106  HERV70 LTRERV1 6053 6100
Del, deletion; Ins, insertion.
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Syncytin. This example is listed by Smit (4) and is included here
because recent evidence shows that Syncytin is a functioning
gene in human placenta (21, 22). The mRNA is derived in toto
from the endogenous retrovirus HERV-W, which is present in
many copies in the human genome. The authors (21) identify
ERVWE1 as the gene region that is the source of the transcript,
although this may not be certain. ERVWE1 is 10.2 kb long and
consists of the usual LTR–gag–pol–env–LTR arrangement. The
Syncytin mRNA is 2.8 kb long and consists of the 5 LTR, some
additional sequence, the env gene, and the 3 LTR. The cds of
1,617 nt includes just the env gene of the endogenous retrovirus.
Within it, regions can be identified that are functionally signif-
icant to Syncytin. It is not clear how much evolutionary change
occurred in the env gene to assume its present function. Entrez
Gene lists what are termed GeneRIFs (www.ncbi.nlm.nih.gov
projectsGeneRIFGeneRIFhelp.html):
Table 4. Observed transcripts that match ME for >80% of their length
Chr. % length*
Length of
cds ID ID % match† Listing‡ Record§
1 98.25 171 NM016646 LOC51336 82.7 L1M3
1 96.00 150 XM352936 PRO2012 78.1 L1ME Record removed
2 100.00 384 NM175853 LOC150759 78.7 L1P
2 100.00 375 XM208704 LOC283517 97.9 SVA Record removed
2 100.00 723 XM351431 LOC375197 95.8 L1PA4 Record removed
2 95.83 288 XM173068 LOC253584 85.4 THE1C MLT1B
2 92.33 300 XM351509 LOC375299 90.0 L1P Tigger2 Record removed
2 86.38 279 XM291017 LOC339793 89.8 L1P MLT1E2
3 93.44 183 NM018629 PRO2533 76.3 MLT1G3 Record removed
3 91.54 402 XM353342 LOC375388 79.9 MLT2B4 Record removed
3 83.66 153 NM014135 PRO0641 78.1 MLT1H Record removed
4 99.95 1974 XM209656 LOC285550 89.8 Charlie9
4 97.40 1692 NM024534 FLJ12684 72.6 MER34-int
5 87.04 486 NM173668 FLJ34836 89.1 LTR12C BaEV-int MER50
5 86.45 369 XM353366 LOC375433 81.2 L1MCD LTR5B Record removed
6 99.74 387 XM291181 LOC340211 97.4 L1P
6 99.60 249 NM018572 PRO1051 87.9 L1P Record removed
6 84.97 366 NM178534 FLJ37940 85.7 HERVL18 Record removed
7 97.72 1491 NM032203 GTF2IRD2 82.4 Charlie8
7 94.02 1722 NM145111 DKFZp727G1 86.4 Charlie9
8 97.99 348 XM351783 LOC375668 86.8 Tigger3 (Golem) FLAMC removed
8 85.35 273 XM353456 LOC375664 70.3 L2 Record removed
9 100.00 375 XM209180 LOC284397 97.1 SVA
9 100.00 342 XM351803 LOC375700 87.4 L1P4 Record removed
9 100.00 363 XM353472 LOC375692 82.8 LTR1B Record removed
9 92.10 291 XM353479 LOC375732 73.1 SST1 Record removed
9 92.10 291 XM353476 LOC375716 72.8 SST1 Record removed
9 91.75 291 XM353477 LOC375726 72.6 SST1 Record removed
9 90.14 426 NM030898 FLJ21673 84.1 AluSgx L2 FLAMA record removed
9 90.11 354 XM353493 LOC375772 93.1 MLT2A1 Record removed
9 88.52 270 XM353481 LOC375740 77.4 REP522 Record removed
9 88.52 270 XM353480 LOC375738 77.8 REP522 Record removed
9 88.52 270 XM353478 LOC375727 77.4 REP522 Record removed
10 99.67 600 NM178512 FLJ37201 73.2 Tigger4 (Zombi)
10 99.57 231 XM352893 LOC374280 90.4 MER11B Record removed
10 98.10 105 NM173577 MGC45541 86.4 AluJoFRAM
1 85.21 2082 NM021211 LOC58486 68.3 Charlie1
12 85.48 303 XM350891 LOC374483 93.8 HERVK22 Record removed
13 99.31 288 NM138474 LOC144845 80.1 L1PA13 Record removed
13 97.80 501 NM173604 FLJ25694 87.4 HERVE
13 89.24 381 NM153251 FLJ25952 85.5 AluSgx AluSx
13 80.13 297 XM353050 LOC374511 77.0 MSTC MIR Record removed
16 100.00 75 NM030970 MGC3771 90.7 AluSp
19 100.00 144 NM178523 MGC45556 91.0 L1PA10 Record removed
19 88.17 372 XM294914 LOC339358 81.2 MER41-int MER41B MER77
19 84.00 225 NM138781 LOC113386 77.8 HERVK3
20 100.00 375 XM209370 LOC284806 89.1 SVA Record removed
21 88.89 378 XM211658 LOC284837 75.3 L1MB8 Record removed
X 100.00 372 NM153016 FLJ30672 87.8 THE1-int
Chr., chromosome.
*Percent of length of cds that is ME.
†Percent sequence match of cds to ME.
‡REPEATMASKER listing.
§Added on March 2, 2004, when removals were found.
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1. Env HERV-W glycoprotein mediates cell–cell fusion upon
interaction with the type D mammalian retrovirus receptor.
Env protein was detected in the placental syncytiotropho-
blast, suggesting a physiological role during pregnancy and
placenta formation.
2. Contributor to normal placental architecture, especially in the
fusion processes of cytotrophoblasts to syncytiotrophoblasts.
The gene expression of Syncytin may be altered in cases with
placental dysfunction such as preeclampsia or HELLP syn-
drome.
3. mRNA abundance for Syncytin showed stimulation by fors-
kolin in BeWo cells.
4. Syncytin-mediated trophoblastic fusion in human cells is
regulated by GCMa.
5. Syncytin gene activation is highest in term placenta.
6. HERV-W Env glycoprotein is directly involved in the differ-
entiation of primary cultures of human villous cytotropho-
blasts.
7. Hypoxia alters expression and function of Syncytin and its
receptor during trophoblast cell fusion of human placental
BeWo cells: Implications for impaired trophoblast syncytial-
ization in preeclampsia.
8. Syncytin gene expression is down-regulated by hypoxia, which
strengthens the hypothesis that Syncytin is reduced in dis-
turbed pregnancies in the course of placental hypoxia.
HHCM.HHCM is identified as a human hepatocellular carcinoma
3.0-kb DNA sequence that encodes (in a 1,404-nt cds) a 52-kDa
protein. It transforms both rat liver cells and NIH 3T3 fibro-
blasts.† Table 1 shows that it is almost 90% made up of L1 MEs.
The sequencematch is only70%, somuch sequence change has
occurred because its origin from a part of the L1 sequence. It
matches the regions 18–331 nt and 437-1470 nt of L1MD2. This
is not apparently a beneficial contribution that L1 has made to
our genome, although MEs act in strange ways. The record
NM006543 was ‘‘temporarily removed by RefSeq staff for
additional review’’ and Smit (personal communication) did not
find a closely matching genomic sequence. Thus, this example
must be considered a candidate for future study.
LG30.LG30 is a gene of unknown function in the regionG72G30
of chromosome 13. Mutations in the region are connected to
bipolar disorder (23, 24), but it appears that the G72 is more
likely to be responsible (25). The LG30 coding region is only 216
nt long, and 100% of its length is related to LTR class ME
(MLT1E, MLT1G).
GTF2IRD2. GTF2IRD2 was initially described as a transcription
factor gene (26, 27), and the NCBI entry consisted of the
fragment listed in Table 1. That is why it is included here. It has
recently been studied in detail (28, 29), and it turns out that this
fragment is actually exon 16, the 3 exon and the only long exon,
more than half the length of the whole coding sequence. This
exon consists entirely of ME sequence Charlie8. What follows is
a quotation from ref. 29. ‘‘GTF2IRD2 is the third member of the
novel TFII-I family of genes clustered on 7q11.23. The
GTF2IRD2 protein contains two putative helix–loop–helix re-
gions (I-repeats) and an unusual C-terminal CHARLIE8 trans-
poson-like domain, thought to have arisen as a consequence of
the random insertion of a transposable element generating a
functional fusion gene. The retention of a number of conserved
transposase-associated motifs within the protein suggests that
the CHARLIE8-like region may still have some degree of
transposase functionality that could influence the stability of the
region in a mechanism similar to that proposed for Charcot–
Marie–Tooth neuropathy type 1A. GTF2IRD2 is highly con-
served in mammals and the mouse orthologue (Gtf2ird2) has
also been isolated.’’
Other Transcript Coding Sequences Apparently Derived from ME.
Table 4 is a list of 49 examples of observed transcripts for which
the coding sequences have been determined by computer
programs, and these cds are made up from MEs at least to the
extent of 80%. This collection was made by running REPEAT-
MASKER against the NCBI collection of gene transcripts in
February of 2004, but when checks were made in early March,
all of the transcripts so marked had been removed from the
collection. It seems likely that someone decided they were
junk, which in a sense may be true, but from the point of view
of this article they may be considered potentially useful and
should be further examined. Some of them are likely to be
examples of the transcription of fragments of ME, a process
which occurs frequently. Regions of ME line 1 are expressed
in mouse and rat and human RNA collections (unpublished
data). Smit’s table (4) has been extended (27) to include 47
potential genes derived at least in part from ME. However, the
central issue for these two tables is whether these candidates
are actually functioning genes. In fact, there is no evidence in
the majority of cases that these mRNAs are produced by
functioning genes. There are two examples in these tables
where nearly the whole mRNA derives from an ME, and one
of them is described above as Syncytin (21, 22). The other
appears to be the transcription of a fragment of a sequence
related fairly closely to HERV3, including the env gene and
LTR, and the transcript is described as an env gene mRNA.
The evidence of its function is transcription in placental
trophoblast cells (28), reminiscent of intracysternal A-particles
in mouse that are similar to ERVs and may be claimed to have
an important role in placenta (29).
The cases described and possibly the example just mentioned
(4, 27) show that parts of ME have been converted to form
essentially complete gene coding sequences. There are probably
more cases as indicated by Table 4. These observations add to the
many known ways in which MEs have contributed to our
evolution. This subject has been reviewed recently by Kazazian
(30) who characterizes them as being in the driver’s seat, rather
than simply being useful to have around. Because of this review
there is not reason for extensive discussion here.
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